We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

This study has been terminated.
(The study was discontinued due to unfavorable interim analysis)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00484536
First Posted: June 11, 2007
Last Update Posted: September 12, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Biogen
Information provided by (Responsible Party):
UCB Pharma
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: January 20, 2011